• N. Yu. Bohun
  • T. I. Klimenko
  • L. L. Kleschevnykova
  • D. V. Molodan
Keywords: the Pickwikian syndrome, obesity-hypoventilation syndrome, lifestyle modification


The article demonstrates a clinical case of Pickwickian syndrome. The clinical manifestation of the syndrome, a diagnostic approach including instrumental methods, and the up-to-date treatment based on the literature data are shown. The significance of maintaining lifestyle modification with accent on a normalization of body mass is emphasized.


Download data is not yet available.


1. Littleton S. W. The pickwickian syndrome-obesity hypoventilation syndrome. / S. W. Littleton,
B. Mokhlesi // Clin Chest Med. – 2009. – No. 30 (3). – p. 467–478.
2. HealthCentral Encyclopedia [electronic resource]. – Access mode: – overview.
3. Mokhlesi B. Obesity Hypoventilation Syndrome: A State-of-the-Art Review / B. Mokhlesi // Respir. Care. – 2010. – No. 55 (10). – p. 1347–1365.
4. Piepoli M. F. 2016 European guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) / M. F. Piepoli, A. W. Hoes, S. Agewall et al] // Eur Heart J. – 2016. – No. 37 (29). – p. 2315–2381.
5. Knipe H. Pickwickian syndrome [electronic resource] / H. Knipe, R. Pfleger. – Access mode: – overview.
6. Akboga M. K. Platelet to lymphocyte ratio as a novel indicator of inflammation is correlated with the severity of metabolic syndrome: A single center large-scale study / M. K. Akboga, U. Canpolat,
M. Yuksel et al] // Platelets. – 2016. – No. 27. – p. 178–183.
7. Jung U. J. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease / U. J. Jung, M. S. Choi // Int J Mol Sci. – 2014. – No. 15 (4). – p. 6184–6223.
8. Pearson T. A. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. / T. A. Pearson, G. A. Mensah, R. W. Alexander, et al] // Circulation. – 2003. – No. 107 (3). – p. 499–511.
9. Casas J.P. C-reactive protein and coronary heart disease: a critical review. / J.P. Casas, T. Shah, A.D. Hingorani, et al] // J Intern Med. –2008. – No. 264(4).–p. 295–314.
10. Edmond H. L. Obesity Hypoventilation Syndrome and Anesthesia / H. L. Edmond, B. Mokhlesi, F. Chung // Sleep Med Clin. – 2013. – No. 8(1). – p. 135–147.
11. Geraldo M. S. The use of drugs in patients who have undergone bariatric surgery / M. S. Geraldo, F. L. Fonseca, M. R.Gouveia, D. Feder // Int J Gen Med. – 2014. – No. 14. – p. 219–224.
How to Cite
Bohun, N. Y., Klimenko, T. I., Kleschevnykova, L. L., & Molodan, D. V. (2017). THE PICKWICKIAN SYNROME CASE. The Journal of V. N. Karazin Kharkiv National University, Series "Medicine", (34), 63-67. Retrieved from
Clinical case